Candesartan Cilexetil - CAS 145040-37-5
Catalog number: B0046-463851
Category: APIs
Molecular Formula:
C33H34N6O6
Molecular Weight:
610.65
COA:
Inquire
Description:
Candesartan Cilexetil is a prodrug of candesartan, a nonpeptide angiotensin II receptor inhibitor used for the treatment of high blood pressure. Candesartan selectively blocks and dissociates slowly from the angiotensin II subtype 1 (AT1) receptor.
Ordering Information
Catalog Number Size Price Stock Quantity
B0046-463851 50 g $450 In stock
Bulk Inquiry
Appearance:
White to Off-white Solid
Synonyms:
Atacand; TCV-116; Amias; 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
MSDS:
Inquire
Melting Point:
161-163˚C
InChIKey:
GHOSNRCGJFBJIB-UHFFFAOYSA-N
InChI:
InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)
Canonical SMILES:
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC6
1. Systematic development of novel cationic self-nanoemulsifying drug delivery systems of candesartan cilexetil with enhanced biopharmaceutical performance
Gajanand Sharma, Sarwar Beg, Kaushik Thanki, Sanyog Jain,* Bhupinder Singh*. RSC Adv.,2015, 5,71500–71513
Candesartan cilexetil is popularly recommended for the treatment and management of hypertension. However, its therapeutic efficacy gets markedly reduced owing to low oral bioavailability as a function of poor solubility, extensive hepatic first-pass effect and high P-glycoprotein (P-gp) efflux. Several formulation strategies including solid dispersions, cosolvates, nclusion complexes and nanosuspensions have been under-taken to enhance the oral bioavailability of candesartan cilexetil. However, none of these formulations are found to be highly effective to address the low oral bioavailability issues, as these tend to deal with the poor solubility issue only. Lately, self-nanoemulsifying drug delivery systems (SNEDDS) have been extensively investigated for augmenting the oral absorption of highly lipophilic drugs owing to their inherent potential to improve drug solubility and permeability, and eventually its oral bioavailability.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 152-11-4 Verapamil hydrochloride

Verapamil hydrochloride
(CAS: 152-11-4)

Verapamil is a medication for the treatment of high blood pressure, angina and supraventricular tachycardia. It acts via blocking voltage-dependent calcium chan...

CAS 147245-92-9 Glatiramer acetate

Glatiramer acetate
(CAS: 147245-92-9)

Glatiramer acetate is an immunomodulator drug currently used to treat multiple sclerosis. It is a random polymer of four amino acids found in myelin basic prote...

CAS 27220-47-9 Econazolum

Econazolum
(CAS: 27220-47-9)

Econazole, structurally similar to miconazole, is an effective antifungal drug.

CAS 112809-51-5 Letrozole

Letrozole
(CAS: 112809-51-5)

CAS 52-86-8 Haloperidol

Haloperidol
(CAS: 52-86-8)

CAS 123447-63-2 Prulifloxacin

Prulifloxacin
(CAS: 123447-63-2)

CAS 123040-69-7 Azasetron HCl

Azasetron HCl
(CAS: 123040-69-7)

Chemical Structure

CAS 145040-37-5 Candesartan Cilexetil

Quick Inquiry

Verification code

Featured Items